Clinical Therapeutic Evaluation Program in Patients With Rheumatic Diseases
Clinical Therapeutic Evaluation Program in Patients With Rheumatic Diseases
Study to evaluate the efficacy and safety of meloxicam (Mobicox®) in Mexican population with rheumatic diseases.
Inclusion Criteria:
Exclusion Criteria: